Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Morosato

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
International Journal of Clinical & Laboratory Research|January 1, 1995
Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disordersF Vinante, A Vassanelli, R Zanotti, et al.
Haematologica|May 1, 1996
Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiationF Vinante, A Rigo, C Tecchio, et al.
British Journal of Haematology|May 1, 1993
ICAM-1 tissue overexpression associated with increased serum levels of its soluble form in Hodgkin's diseaseG Pizzolo, F Vinante, G Nadali, et al.
AIDS (London, England)|July 1, 1991
Shedding of the soluble form of the CD8 complex by CD8+/HLA-DR+ cells in HIV-1-infected patientsC Agostini, G Pizzolo, R Zambello, et al.
AIDS (London, England)|June 1, 1994
High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDSG Pizzolo, F Vinante, L Morosato, et al.
Leukemia|June 1, 1995
Leukemic cells in hairy cell leukemia and B cell chronic lymphocytic leukemia release soluble TNF receptorsL Trentin, G Pizzolo, R Zambello, et al.
Cancer|July 1, 1993
Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcomeA Ambrosetti, G Nadali, F Vinante, et al.
Haematologica|September 1, 1994
Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosisF Vinante, L Morosato, F Siviero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large-cell lymphomaG Nadali, F Vinante, H Stein, et al.
International Journal of Clinical & Laboratory Research|January 1, 1993
Soluble interleukin-2 receptor in hairy-cell leukemia: a reliable marker of diseaseA Ambrosetti, G Nadali, F Vinante, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Clinical & Laboratory Research|January 1, 1995
Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disordersF Vinante, A Vassanelli, R Zanotti, et al.
Haematologica|May 1, 1996
Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiationF Vinante, A Rigo, C Tecchio, et al.
British Journal of Haematology|May 1, 1993
ICAM-1 tissue overexpression associated with increased serum levels of its soluble form in Hodgkin's diseaseG Pizzolo, F Vinante, G Nadali, et al.
AIDS (London, England)|July 1, 1991
Shedding of the soluble form of the CD8 complex by CD8+/HLA-DR+ cells in HIV-1-infected patientsC Agostini, G Pizzolo, R Zambello, et al.
AIDS (London, England)|June 1, 1994
High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDSG Pizzolo, F Vinante, L Morosato, et al.
Leukemia|June 1, 1995
Leukemic cells in hairy cell leukemia and B cell chronic lymphocytic leukemia release soluble TNF receptorsL Trentin, G Pizzolo, R Zambello, et al.
Cancer|July 1, 1993
Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcomeA Ambrosetti, G Nadali, F Vinante, et al.
Haematologica|September 1, 1994
Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosisF Vinante, L Morosato, F Siviero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large-cell lymphomaG Nadali, F Vinante, H Stein, et al.
International Journal of Clinical & Laboratory Research|January 1, 1993
Soluble interleukin-2 receptor in hairy-cell leukemia: a reliable marker of diseaseA Ambrosetti, G Nadali, F Vinante, et al.
Pageof 3